Table 3.xls (5.5 kB)
A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day acquisition of multi-drug resistant bacterial and fungal infections for 151 patients with ESBL-producing E. coli and K. pneumoniae bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.
dataset
posted on 2016-04-22, 06:20 authored by Tat Ming Ng, Wendy X. Khong, Patrick N. A. Harris, Partha P. De, Angela Chow, Paul A. Tambyah, David C. LyeA propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day acquisition of multi-drug resistant bacterial and fungal infections for 151 patients with ESBL-producing E. coli and K. pneumoniae bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.
